Status:
COMPLETED
A Trial of Paclitaxel and Bevacizumab vs. Gemcitabine, Paclitaxel, and Bevacizumab in Advanced Breast Cancer
Lead Sponsor:
Eli Lilly and Company
Collaborating Sponsors:
Genentech, Inc.
Conditions:
Breast Cancer
Eligibility:
FEMALE
18+ years
Phase:
PHASE2
Brief Summary
This study will compare the cancer response to both treatments for locally advanced or metastatic breast cancer
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Females diagnosed with breast cancer and the cancer has spread to distant areas of the breast or organs.
- Must be able to measure the disease by specific medical parameters
- May have received breast cancer treatment in the early stage of the disease
- May be restricted in physically strenuous activity but able to carry out light work.
- Must have adequate organ function as seen in blood test results.
- Exclusion
- Criteria:
- Cancer that has spread to the brain.
- Unstable heart problems
- Unstable high blood pressure.
- Breast cancer treatment after the disease has considered to spread to other areas or organs.
- Unable to agree with the requirements of the study
Exclusion
Key Trial Info
Start Date :
May 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2012
Estimated Enrollment :
187 Patients enrolled
Trial Details
Trial ID
NCT00320541
Start Date
May 1 2006
End Date
August 1 2012
Last Update
July 22 2013
Active Locations (32)
Enter a location and click search to find clinical trials sorted by distance.
1
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Fayetteville, Arkansas, United States, 72703
2
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
La Jolla, California, United States, 92037
3
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Mission Hills, California, United States, 91345
4
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Santa Rosa, California, United States, 95403